Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension

American Journal of Cardiology

Volumn 86, Issue 5, 2000, Pages 514-518

  Su, Sheng Fang ^a   Hsiao, Chia Ling ^a   Chu, Chia Wei ^a   Lee, Bai Ching ^b   Lee, Tsung Ming ^a  

^a Dept Clin Pharm Natl Cheng K ^*  (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; PRAVASTATIN;

EID: 0034284485     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01004-3     Document Type: Article

References (27)

1. Schaich M.P., Schmieder R.E. Left ventricular hypertrophy and its regression pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents . Am J Hypertens. 11:1998;1394-1404.
2. Castelli W.P., Anderson K. A population at risk prevalence of high cholesterol levels in hypertensive patients of the Framingham Study . Am J Med. 80:(suppl 2A):1986;23-32.
3. Jenkins G.H., Grieve L.A., Yacoub M.H., Singer D.R.J. Effects of simvastatin on ejection fraction in cardiac transplantation recipients. Am J Cardiol. 78:1996;1453-1456.
4. Kreuzer J., Watson L., Herdegen T., Loebe M., Wende P., Kubler K. Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II-mediated signal transduction suppression of c-Jun and c-Fos in human smooth muscle cells in vitro . Eur J Med Res. 4:1999;135-143.
5. Alfie J., Waisman G.D., Galarza C.R., Camera M.I. Contribution of stroke volume to the change in pulse pressure pattern with age. Hypertension. 34:1999;808-812.
6. Lee T.M., Su S.F., Chen M.F., Liau C.S., Lee Y.T. Effects of increasing flow rate on aortic stenotic indices evidence from percutaneous transvenous balloon dilation of the valve in patients with combined aortic and mitral stenosis . Heart. 76:1996;490-494.
7. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings . Am J Cardiol. 57:1986;450-458.
8. Reichek N., Wilson J., Sutton M.S., Plappert T.A., Goldberg S., Hirshfeld J.W. Noninvasive determination of left ventricular end-systolic stress validation of the methods and initial application . Circulation. 65:1982;99-108.
9. Tsai C.H., Lee T.M., Wang C.H., Hsu K.L., Liau C.S., Lee Y.T., Chu S.H. Effects of dobutamine on aortic valve indexes in asymptomatic patients with bileaflet mechanical prostheses in the aortic valve position. Am J Cardiol. 79:1997;1546-1549.
10. Randall O.S., Westerhof N., Van Den Bos G.C., Alexander B. Reliability of stroke volume to pulse pressure ratio for estimating and detecting changes in arterial compliance. J Hypertens. 4:(suppl 5):1986;S293-S296.
11. Allain L.A., Poon L.S., Chan L.S.G., Richmond W., Fu P.L. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475.
12. McGowan M.W., Artiss J.D., Strandbergh D.R., Zak B. A peroxidase-coupled method for colorimetric determination of serum triglycerides. Clin Chem. 29:1983;538-542.
13. Warnick G.R., Knopp R.H., Fitzppatrick V., Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem. 36:1990;15-19.
14. Thurmann P., Stephens N., Heagerty A.M., Kenedi P., Weidinger G., Rietbrock N. Influence of isradipine and spirapril on left ventricular and resistance arteries. Hypertension. 28:1996;450-456.
15. Yang B.C., Phillips M.I., Mohuczy D., Meng H., Shen L., Mehta P., Mehta J.L. Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits. Arteroscler Thromb Vasc Bio. 18:1998;1433-1439.
16. Nickenig G., Baumer A.T., Temur Y., Kebben D., Jockenhovel F., Bohm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation. 100:1999;2131-2134.
17. Kent R.L., Mann D.L., Cooper G. IV. Signals for cardiac muscle hypertrophy in hypertension. J Cardiovasc Pharmacol. 17:(suppl 2):1991;S7-S13.
18. Ehrhart L.A., Holderbaum D. Stimulation of aortic protein synthesis in experimental rabbit atherosclerosis. Atherosclerosis. 27:1977;477-485.
19. Langner R.O., Modrak J.B. Aortic collagen synthesis in rabbits following removal of atherogenic diet. Exp Mol Pathol. 26:1977;310-317.
20. Relf R.N., Lo C.S., Myers K.A., Wahlqvist M.L. Risk factors for changes in aorto-iliac arterial compliance in healthy men. Arteriosclerosis. 6:1986;105-108.
21. Faggiotto A., Paoletti R. Statins and blockers of the renin-angiotensin system. Vascular protection beyond their primary mode of action. Hypertension. 34:1999;987-996.
22. 2+ responsiveness of smooth muscle contraction. FEBS Lett. 324:1993;211-215.
23. Indolfi C., Avvedimento E.V., Rapaccicuolo A., Di Lorenzo E. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1:1995;541-545.
24. Franz I.-W., Ketelhut R., Behr U., Tonnesmann U. Time course of reduction in left ventricular mass during long-term antihypertensive therapy. J Hum Hypertens. 8:1994;191-198.
25. Wang T.D., Lee C.M., Wu C.C., Lee T.M., Chen W.J., Chen M.F., Liau C.S., Lee Y.T. The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris. Atherosclerosis. 146:1999;117-124.
26. Treasure C.B., Klein J.L., Weintraub W.S., Talley J.D., Stillabower M.E., Kosinski A.S., Zhang J., Boccuzzi S.J., Cedarholm J.C., Alexander R.W. Beneficial effect of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
27. Eichstadt H.W., Eskotter H., Hoffmann I., Amthauer H.W., Weidinger G. Improvement of myocardial perfusion by short-term fluvastatin treatment in coronary artery disease. Am J Cardiol. 76:1998;122A-125A.